Home News Discover the latest breakthroughs, stories, and updates from Oncode Institute’s mission to outsmart cancer. Search Category Category press news Research news All about science: the 2023 KIT Meeting Wrap Up 20 Dec 2023 Oncode Institute zoekt een Communicatie Specialist (32-40 uur per week) 7 Dec 2023 New potential drug suppresses chemotherapy induced neuropathic pain 5 Dec 2023 A common goal: bringing patients and researchers together 29 Nov 2023 Oncode Investigators Rebekka Schneider, Hugo Snippert and Jeroen de Ridder receive ERC Consolidator Grant 23 Nov 2023 Oncode Institute expands with ten talented Junior Investigators 3 Nov 2023 New connections between Oncode researchers and patient partners 30 Oct 2023 Melvin Samsom becomes Chair of Oncode Institute’s Supervisory Board 30 Oct 2023 Oncode Investigator René Bernards (NKI) and LIXTE expand collaboration to test counterintuitive approach to treating cancer 16 Oct 2023 AI technology helps to identify brain tumor type during surgery 11 Oct 2023 Hello Bio announces the launch of a novel cutting-edge range of adenosine receptor probes for cancer & cardiovascular research 27 Sep 2023 Start of Oncode Accelerator: patients at the center of innovative cancer drug development 7 Sep 2023 In memoriam – Erica van Wuijtswinkel 7 Sep 2023 Fatty finding fuels scientists’ understanding of human cells 30 Aug 2023 Jan Paul Medema appointed new Scientific Director and Head of Oncode Institute 30 Aug 2023 More accurate understanding of single-cell DNA change 29 Aug 2023 Pagination Previous page ‹ … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page ›
Oncode Investigators Rebekka Schneider, Hugo Snippert and Jeroen de Ridder receive ERC Consolidator Grant 23 Nov 2023
Oncode Investigator René Bernards (NKI) and LIXTE expand collaboration to test counterintuitive approach to treating cancer 16 Oct 2023
Hello Bio announces the launch of a novel cutting-edge range of adenosine receptor probes for cancer & cardiovascular research 27 Sep 2023
